Here are three things to know about the center.
1. It is the world’s first proton therapy center solely dedicated to children. Proton therapy, used in managing and treating pediatric tumors, allows physicians to administer targeted, high-dose radiation while sparing surrounding healthy tissue from exposure.
2. The center’s rooms are equipped with spot-scanning irradiation, a technology for which Hitachi, a Tokyo, Japan-based multinational conglomerate company, received the first FDA Premarket Notification Special 510(k) clearance in 2007. St. Jude will be Hitachi’s third proton therapy site in the U.S.
3. James Downing, MD, St. Jude president and CEO, called the opening of the St. Jude Red Frog Events Proton Therapy Center “an important step in our efforts to provide therapies that maximize cures while minimizing long-term treatment complications.” He added in a news release, “The center is an engineering marvel made possible through the talents of many who are committed to offering children with cancer the best hope for the future.”
More articles on capacity management:
Many EDs haven’t addressed overcrowding: 5 findings
Chambersburg Hospital to open NICU: 4 things to know
52 hospitals with the fastest ED discharge time
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
